The CALR mutation is found to activate the thrombopoietin (TPO) receptor, MPL, and results in the expansion of the megakaryocytic lineage, which subsequently increases the platelet counts and rate of splenic enlargement in MPN [105]. This evidence concerns the gene MPL and myeloproliferative neoplasm.